MedAccess believes in a world where everyone can access the lifesaving treatments, vaccines, and health technologies they need to live healthy lives. Our goal is to help the world realise SDG3: healthy lives for all by 2030.
We want to transform access to health for millions of people this decade using a blended finance model. We aim to achieve greater scale and deeper impact by combining philanthropic and investor seed funding.
We are looking for visionary seed philanthropists and investors to help us raise $50 million of catalytic capital by 2024. Together we will deliver access to affordable healthcare products at remarkable scale.
Building on our current portfolio, we aim to scale our impact as rapidly as possible. Our social finance, combined with strong public and private sector partnerships, will transform healthcare markets and improve the health of millions of people.
Transform healthcare markets in Africa and south Asia to ensure vital products and medicines reach communities that need them most.
Invest in lifesaving treatments for infectious diseases, continuing our work to accelerate access to vaccines and treatments for HIV, TB, malaria, and maternal and child health.
Pioneer financing solutions for non-communicable diseases including cancer, diabetes, sickle cell and heart disease.
Catalyse affordable access to vaccines, treatments and innovative technologies.
Your support will leverage enduring returns by improving the health of millions of people. Together, we will:
To find out more about this opportunity, please contact Rosalind O’Mahony, our Head of Resource Mobilisation, on romahony@medaccess.org
Supporting UNICEF to secure and distribute vital COVID-19 supplies, including diagnostic tests, oxygen and clinical management supplies.
Partnering with GSK and Gavi to support the continued production of antigen for the malaria vaccine ahead of key policy and funding decisions.